 |
|
| Investigator: |
Phone: (404) 321-6111 ext. 6731
Email: Scott.Edelman@va.gov
|
| Primary Research Interest: |
Radiation Oncology |
| Description of Research: |
Radiation Therapy Oncology Group study 0924, Androgen Deprivation Therapy and High Dose Radiotherapy With or Without Whole-Pelvic Radiotherapy
in Unfavorable Intermediate or Favorable High Risk Prostate Cancer: A Phase III Randomized Trial, is designed to see whether radiotherapy to the draining lymph nodes of the prostate improves outcomes.
Radiation Therapy Oncology Group study 0614 is a randomized, phase III trial of a drug for pervention of conginitive dysfunction in patients receiving whole brain radiotherapy.
RTOG 0815 is a phase III prostpective randiomized trial of dose-escalated radiotherapy with or without short-term androgen deprivation therapy for patients with intermediate-risk prostate cancer.
RTOG 0617 is a randomized study comparing two doses of radiotherapy in the treatment of nonsmall cell lung cancer
RTOG 0831 is a randomized study of whether tadalafil vs placebo helps maintain erection function in patients receiving prostate radiotherapy for cancer. |
| Relevance to VA: |
Many veterans develop cancer and require radiotherapy. The research in which we participate is looking at ways to improve the treatment of such patients. |
| |
|
Privacy Statement 
